BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Integrated DNA Technologies Release: MIQE Guidelines for Consistent qPCR Experimental Design and Reporting


9/13/2012 11:28:17 AM

CORALVILLE, IA – 13 September 2012 – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is proud to host Professor Stephen Bustin from Anglia Ruskin University, Cambridge and Chelmsford, for a webinar entitled MIQE Guidelines: A Roadmap for Proper qPCR Experimental Design and Reporting on Tuesday 25th September 2012 at 7am CDT (1pm BST), repeated at 1pm CDT (7pm BST). Professor Stephen Bustin, who led the international consortium that drew up the MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines (2009), will discuss approaches to ensure that results reported from today’s most widely used molecular technology are robust, accurate, reliable and complete.

Attendees will hear how the ease with which qPCR data can now be generated sometimes conceals experimental practices that result in the publication of inconsistent, inaccurate or simply wrong results. Incomplete reporting of experimental detail often further confounds assessment of qPCR data validity, calling into question scientific conclusions. Professor Bustin will explain how the MIQE guidelines provide researchers with a blueprint for reliable qPCR experimental design, as well as recommendations to ensure comprehensive reporting of technical detail.

Professor Bustin is in constant demand as a speaker and teacher at international qPCR meetings and workshops, having written the “A-Z of Quantitative PCR” (2004), universally acknowledged as the “qPCR Bible” and more recently “The PCR Revolution” (2011). Register now to attend the webinar.

IDT offers a range of informative and educational webinars, all of which are hosted online. Check them out in IDT’s TechVault. For further information about IDT and its portfolio of primers, probes and PrimeTime® qPCR assays, visit www.idtdna.com. Follow us on twitter @idtdna for real-time updates and insights.

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.

Integrated DNA Technologies

800-328-2661 (US & Canada)

+1 319-626-8400 (outside US)

productinfo@idtdna.com

www.idtdna.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES